O. Fain, O. Seror, and J. F. Wirth, Cranial pachymeningitis, Rev Med Interne, vol.20, pp.234-280, 1999.
URL : https://hal.archives-ouvertes.fr/hal-02318130

L. X. Lu, E. Della-torre, and J. H. Stone, IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment, JAMA Neurol, vol.71, pp.785-93, 2014.

A. Yokoseki, E. Saji, and M. Arakawa, Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody, Brain, vol.137, pp.520-556, 2014.

T. Yonekawa, H. Murai, and S. Utsuki, A nationwide survey of hypertrophic pachymeningitis in Japan, J Neurol Neurosurg Psychiatry, vol.85, pp.732-741, 2014.

M. Fujimoto, J. Kira, and H. Murai, Hypertrophic cranial pachymeningitis associated with mixed connective tissue disease; a comparison with idiopathic and infectious pachymeningitis, Intern Med, vol.32, pp.510-512, 1993.

D. Virgilio, A. De-vincentiis, M. Inghilleri, and M. , Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease, Immunol Res, vol.65, pp.386-94, 2017.

Z. S. Wallace, M. N. Carruthers, and A. Khosroshahi, IgG4-related disease and hypertrophic pachymeningitis, Medicine (Baltimore), vol.92, pp.206-222, 2013.

N. E. Onyeuku, N. Balakrishnan, and M. S. Cartwright, Granulomatosis with polyangiitis presenting with pachymeningitis, J Neurol Sci, vol.344, pp.208-217, 2014.

E. Reinhold-keller, K. De-groot, and K. Holl-ulrich, Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature, Clin Exp Rheumatol, vol.19, pp.541-550, 2001.

A. Sharma, S. Kumar, and A. Wanchu, Successful treatment of hypertrophic pachymeningitis in refractory Wegener's granulomatosis with rituximab, Clin Rheumatol, vol.29, pp.107-117, 2010.

D. Luna, G. Terrier, B. Kaminsky, and P. , Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes, Rheumatology (Oxford), vol.54, pp.424-456, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01710567

Y. Harabuchi, K. Kishibe, and K. Tateyama, Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): a retrospective analysis of 235 patients from a nationwide survey in Japan, Mod Rheumatol, vol.27, pp.87-94, 2017.

E. L. Diamond, L. Dagna, and D. M. Hyman, Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease, Blood, vol.124, pp.483-92, 2014.

J. Haroche, F. Cohen-aubart, and L. Arnaud, Erdheim-Chester disease
URL : https://hal.archives-ouvertes.fr/hal-01251639

, Rev Med Interne, vol.35, pp.715-737, 2014.

L. Arnaud, B. Hervier, and A. Neel, CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients, Blood, vol.117, pp.2778-82, 2011.

G. K. Dash, B. Thomas, and M. Nair, Clinico-radiological spectrum and outcome in idiopathic hypertrophic pachymeningitis, J Neurol Sci, vol.350, pp.51-60, 2015.

. Mekinian, , vol.97, p.30, 2018.